New shot tested to halt dangerous Muscle-Weakening crises
NCT ID NCT07215949
Summary
This study is testing whether daily injections of the drug zilucoplan can quickly relieve the most severe symptoms of a myasthenia gravis flare-up, such as breathing or swallowing problems, in people who need to be hospitalized. The goal is to see if this treatment works faster and is less invasive than current standard hospital treatments like plasma exchange. About 15 adults with a specific type of myasthenia gravis will receive the injections for 12 weeks to measure symptom improvement.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS (GMG) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.